GoodGut’s Post

Did you know that Sinai Health is at the forefront of improving and advancing care, research and our understanding of gastrointestinal cancers such as colon cancer? From hosting one of the most extensive gastrointestinal genetics registries, pivotal for early cancer detection and understanding hereditary risks, to deciphering tumour genetics for personalized therapy decisions, Sinai Health leads the charge in groundbreaking medical advancements and care. When colorectal cancer is caught early enough through screening, someone with the disease has a nine out of 10 chance of being cured. Learn more about what we do here: https://bit.ly/3VagMjj #GastrointestinalCancerAwareness #ColorectalCancerAwareness #dressinblue

Researchers have found that, for people with no family history of CRC and no signs of colorectal cancer in their first colonoscopy screen, the time between screening could be increased from 10 years to 15 years. This could avoid unnecessary invasive examinations. Read more ➡ https://lnkd.in/eTSgBadz #CRC #ColorectalCancer #Colonoscopy #Screening Fiona Beck JAMA Oncology Qunfeng Liang Jan Sundquist Hermann Brenner Elham Kharazmi, MD, PhD Trasias Mukama Kristina Sundquist Mahdi Fallah EU Science, Research and Innovation EU Health and Food Safety Colorectal Cancer Alliance Colorectal Cancer Canada European Colorectal Congress (ECC) Colorectal Cancer Research Network Fight Colorectal Cancer Citrus Colorectal Cancer Foundation Colorectal Disease

Survival rates and approaches to #PancreaticCancer vary greatly between European countries due to differences in #prevention, #screening, #diagnostics, and #treatment. 🎯 Goals to Achieve: 🔹Boost epidemiological research to understand each country's needs. 🔹Support Countries in improving quality approaches. Read more in our position paper👉 https://lnkd.in/eGnV6G97 #2024EUElections #EUCancerPlan #CancerCare #CancerPatients Pancreatic Cancer Europe Digestive Cancers Europe UEG - United European Gastroenterology European Pancreatic Club (EPC)

I'm thrilled to share the news that our Research Letter is accepted for publication in Gastroenterology (American Gastroenterological Association (AGA)), titled: "Use of Fecal Immunochemical Testing (FIT) for risk stratification of patients with symptoms of colorectal cancer referred for diagnostic colonoscopy". In this article we highlight that if FIT is used at the lowest measurable treshold (35ng Hb/ml = 7μg Hb/g) in symptomatic patients (kræftpakkeforløb) 10% of colorectal cancer will still be missed. Implementation of this selection tool in the urgent cancer pathway, like is done in the UK, might not be the right choice for other countries. A sincere thanks to my supervisors and co-authors Jakob Kleif, Malene R. Andersen, John Gásdal Karstensen & Christina Therkildsen. Article in press: https://lnkd.in/dtVudQJM #CopenhagenUniversity Københavns Universitet - University of Copenhagen #HvidovreHospital Gastroenheden Hvidovre Hospital

Here are some of the highlights of my State of the art talk on #Endoscopic #cancer #ablation at the American Society for Gastrointestinal Endoscopy (ASGE) learning center last week at Digestive Disease Week® (DDW) Cancer ablation is still in its infancy and has a lot of potential. Areas that are well established today include #pancreatic #neuroendocrine #cancer and #cryotherapy for #esophagealcancer. Areas of future interest include #pancreaticcancer and low #rectal cancer The drivers include: •Fast paced technological innovation in #medicine and #endoscopy •Desire for #organpreservation and more focus on quality of life •Advancement in #cancer treatment making systemic therapy more effective •Possible #genomic difference between the metastasis and the primary #gastrointestinal cancers •Interest in manipulating the #tumor #microenvironment and antitumor #immune response 

#Molecular_Imaging is a technology which used to characterize and measure the #biological process at the cellular and #molecular level using #imaging detectors. They offer personalized approach to evaluate and manage the cardiovascular diseases and has become an integral part of standard care for several types of cancer including breast, lung and gastrointestinal cancer.

This is optimal.

Common symptoms of esophageal cancer include difficulty swallowing (dysphagia), unintentional weight loss, chest pain or discomfort, and persistent indigestion or heartburn. Early detection can substantially enhance outcomes. Endoscopy is a common prevalent diagnostic method for esophageal cancer, particularly in individuals exhibiting risk factors or symptoms. If you have any of the above symptoms you may want to consult with your local gastroenterologist. Visit: Esophageal Cancer Action Network - Esophageal Cancer Action Network (https://hubs.li/Q02scx6w0) #EsophagealCancerAwarenessMonth #ECAN #Laborie #ForDignityForLife

Don't wait until you're 45 years old: Talk to your doctor about Colorectal Cancer screening even if you're not yet 45, screening might be right for you. Nektarios Demetrious, D.O. emphasizes a concerning rise in young adult cases. Talk to your doctor about your risk factors and whether early screening is recommended for you. Learn more here ➡️ https://lnkd.in/eG5ZqHsK

NEW PUBLICATION IN EUROPEAN JOURNAL OF CANCERS The #liver is the most frequent site of #metastases in #colorectal #cancer (CRC). This study aimed to assess the response rate and survival outcomes in metastatic CRC patients with non-liver metastases (NLM) compared to those with liver metastases (LM) across different lines of treatment. A total of 17,924 mCRC patients included in 26 trials from the ARCAD CRC database were analyzed.  This study reported that liver metastases are generally a poor prognostic factor, particularly in later lines of treatment for mCRC patients, except when anti-EGFR therapy is used in the first and second lines. It also justifies using liver metastases as a stratification factor in future clinical trials for mCRC. #LivermetastaticColorectalCancer #Prognosticvalue #Chemotherapy #TargetedTherapy Morteza Raeisi Benoist Chibaudel Thierry André Qian Shi Takayuki Yoshino Chiara Cremolini Digestive Cancers Europe